Last week, ANAB announced the accreditation of Phoenix, Arizona-based Pure Labs, LLC to ISO/IEC 17025.
Following the launch of Europe’s first medical cannabis Exchange Traded Fund (ETF), which aims to provide targeted exposure to the rapidly expanding medical cannabis industry, there is renewed interest and buzz in the European cannabis market for investors on a domestic and global scale. Whilst there is recent news of major North American cannabis companies undertaking cost reduction exercises, this is reflective of rapid expansion being curtailed to drive profitability, and also something the market has been expecting. The cannabis sector will evolve as the regulatory landscape develops.
Germany imported close to 7.5 tons of medical cannabis flower last year – but what is the real temperature of the market?
A move to cultivate cannabis would also coincide with banning the importation of high proof alcoholic beverages.
Regulators in Maine have chosen to go with Metrc for their traceability software, executing a six-year contract with the software company and making it the 13th state to enter a contract with the provider.
Will New York be the next state to legalize adult use cannabis? Peter Cifichiello details the possibilities, the realities and the prospect of the Empire State following through on Governor Cuomo’s promises.
Act Locally, Impact Globally: Germans In Lahr lead protest for normalization.
There is again a great deal of promise building on the progress of the global CBD market. But what is real and what is hype as headwinds continue to buff the industry?
What does a global spotlight bode for the continued progress of a still revolutionary industry?
From consolidation to maturation: find out what Melissa Kuipers Blake thinks will be the biggest trends for the cannabis industry this year.
